tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Kymera Therapeutics (KYMR) Similar Stocks

Compare
400 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kymera Therapeutics
$83.99
$6.63B
-23.35
114.59%
21 Buy
0 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$86.05
$5.38B
135.85
107.40%
12 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$24.65
$3.12B
83.02
-25.78%
9 Buy
6 Hold
1 Sell
Moderate Buy
Crinetics Pharmaceuticals
$48.01
$4.56B
-10.43%
14 Buy
1 Hold
0 Sell
Strong Buy
Akero Therapeutics
$54.65
86.26%
MoonLake Immunotherapeutics
$13.39
$955.69M
-4.02
-74.19%
10 Buy
5 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KYMR
Kymera Therapeutics
83.99
43.20
105.91%
PTGX
Protagonist Therapeutics
86.05
45.45
111.95%
APLS
Apellis Pharmaceuticals
24.65
-8.56
-25.78%
CRNX
Crinetics Pharmaceuticals
48.01
-5.95
-11.03%
AKRO
Akero Therapeutics
54.65
26.28
92.63%
MLTX
MoonLake Immunotherapeutics
13.39
-38.75
-74.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts